mekinist
novartis europharm limited - trametinib - melanoma - antineoplastična sredstva - melanomatrametinib as monotherapy or in combination with dabrafenib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 in 5. trametinib monotherapy has not demonstrated clinical activity in patients who have progressed on a prior braf inhibitor therapy (see section 5. adjuvant treatment of melanomatrametinib in combination with dabrafenib is indicated for the adjuvant treatment of adult patients with stage iii melanoma with a braf v600 mutation, following complete resection. non-small cell lung cancer (nsclc)trametinib v kombinaciji z dabrafenib je indiciran za zdravljenje odraslih bolnikov z napredovalim non-small cell lung cancer z braf v600 mutacija.
tafinlar
novartis europharm limited - dabrafenib mesilate - melanoma - antineoplastična sredstva - melanomadabrafenib as monotherapy or in combination with trametinib is indicated for the treatment of adult patients with unresectable or metastatic melanoma with a braf v600 mutation (see sections 4. 4 in 5. adjuvant zdravljenje melanomadabrafenib v kombinaciji z trametinib je primerna za adjuvant zdravljenje odraslih bolnikov z faza iii melanoma z braf v600 mutacije, po popolna resekcija. non-small cell lung cancer (nsclc)dabrafenib in combination with trametinib is indicated for the treatment of adult patients with advanced non-small cell lung cancer with a braf v600 mutation.
ubrostar
boehringer ingelheim vetmedica gmbh binger str -
novuxol mazilo
t.j. smith & nephew limited - klostridio-peptidaza; proteaze, druge - mazilo - klostridio-peptidaza 1,2 i.e. / 1 g proteaze, druge0,24 i.e. / 1 g; proteaze, druge 0,24 i.e. / 1 g - kolagenaza
benil 1 mg/1 ml kapljice za nos, raztopina, za odrasle
krka, d.d., novo mesto - nafazolin - kapljice za nos, raztopina - nafazolin 0,77 mg / 1 ml - nafazolin